The Enlarged Board of Appeal of the EPO has decided that products obtained exclusively by an essentially biological process are not patentable

Author: Guillermo Menéndez The Enlarged Board of Appeal (EBoA) of the European Patent Office (EPO) has published the decision of case G3 / 19 (text here) on the patentability, under…

Comments Off on The Enlarged Board of Appeal of the EPO has decided that products obtained exclusively by an essentially biological process are not patentable

ABG Intellectual Property involved in a case wherein an EPO Board of Appeal provides guidance on the selection of suitable starting points within the closest prior art document

On March 2nd 2020 Board of Appeal 3.3.02 of the EPO issued a decision (T 0709/17) providing guidance on the selection of suitable starting points when the closest prior art…

Comments Off on ABG Intellectual Property involved in a case wherein an EPO Board of Appeal provides guidance on the selection of suitable starting points within the closest prior art document

No SPCs for new formulations of previously approved active ingredients

The European Court of Justice (CJEU) released its judgement in the case Abraxis Bioscience LLC v Comptroller General of Patents (C-443/17) on 21 March 2019. In its ruling, the CJUE…

Comments Off on No SPCs for new formulations of previously approved active ingredients
No SPCs for new formulations of previously approved active ingredients
3d Illustration of White Building Construction. Abstract Architecture Background. Interior Design with Columns

The EUIPO creates an information hub on Brexit

ABG IP informs that the EUIPO has recently created in its web page an information hub on Brexit in order to help right holders and representatives of European Union Trademarks…

Comments Off on The EUIPO creates an information hub on Brexit